DFTX R&D Expenses
Definium Therapeutics Inc · R&D Expenses
DFTX R&D Expenses
Latest reported$48.67Mperiod ending
DFTX Quarterly R&D Expenses ($0.00 → $48.67M)
Quarterly R&D Expenses
High-resolution chart · PNG
DFTX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 48,665,000 | |
| 41,484,000 | |
| 33,521,000 | |
| 30,978,000 | |
| 29,809,000 | |
| 23,357,000 | |
| 21,759,000 | |
| 17,188,000 | |
| 14,645,000 | |
| 11,178,000 | |
| 11,546,000 | |
| 13,203,000 | |
| 14,777,000 | |
| 12,599,000 | |
| 8,830,000 | |
| 7,772,000 | |
| 9,326,000 | |
| 10,241,000 | |
| 10,883,000 | |
| 9,019,000 | |
| 8,074,000 | |
| 6,813,000 | |
| 8,157,000 | |
| 5,342,000 | |
| 2,700,000 | |
| 1,803,000 | |
| 425,185 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |